Surgically-BasedDevice VSD Closure Olaf Wendler Department of Cardiothoracic Surgery King‘s College Hospital.

Slides:



Advertisements
Similar presentations
B alloon-pump assisted C oronary I ntervention S tudy BCIS-1 Simon Redwood Kings College London/ St Thomas Hospital Steering Committee: Divaka Perera,
Advertisements

TOF with Absent Pulmonary Valve
Cardiogenic Shock ……………………….and Then Some SCAI C3 Summit Chicago May 12-13, 2006 “I’m Not Dead Yet” Jeffrey F. Bleakley, University of Rochester.
Update of Transcatheter Closure of Ventricular Septal Defect in China Yong-wen Qin Department of Cardiology, Changhai Hospital, Second Military Medical.
Post MI Ventricular Septal Defects Nick Tehrani, MD.
Post-infarction Ventricular Septal Rupture and Free Wall Rupture 서울삼성병원 성균관대학교 김욱성.
POSTINFARCT VSD: OPERATE OR WAIT ?
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
Current Status and Prospect of Interventional Congenital Heart Disease
Simultaneous Coronary Artery Bypass and Carotid Endarterectomy Ye zhidong, Liu Peng Department of Cardiovascular Surgery China-Japan Friendship Hospital.
KING ABDULAZIZ UNIVERSITY HOSPITAL CARDIAC SURGERY UNIT Dr. Khalid Al-Ibrahim Dr. Hussein Jabbad Dr. Khalid Medhat Dr. Ragab Shehata.
Department of Cardiolog Shenyang Northern Hospital
B alloon-pump assisted C oronary I ntervention S tudy BCIS-1 Simon Redwood St Thomas’ Hospital / King’s College London On behalf of the BCIS-1 Investigators.
Ten-Year Follow-up Survival of the Medicine, Angioplasty, or Surgery Study (MASS-II): a Randomized Controlled Clinical Trial of Therapeutic Strategies.
How I would do my anterior VSD Closure
Minimise the damage – Pre- and Post-conditioning Dr Derek J Hausenloy The Hatter Cardiovascular Institute, University College London, UK. Myocardial Recovery.
Department of CTVS.  56 years old male from Cuttack  Date of admission  Date of surgery  Date of death  Diagnosis:
G. Rainey Williams Symposium September 30, 2005 CABG in the Elderly Patient: On or Off pump? A Single Center Experience R. Nathan Grantham, M.D.
Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.
How I Would Do My Inferior-Basal VSD Repair Tirone E. David University of Toronto.
Closure of ventricular septal defect,continous versus conventional closure, comparative study.
The Placement of Atrial Pacing Leads in Patients after Cardiac Surgery
PCI v CABG Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
Bispectral Index Guided Anesthetic Practice in Cardiac Surgery Dr. Mohamed Essam, MD Assistant Professor, Anesthesia Department Ain Shams University.
AB 1/03 Non-Coronary Intervention Circulatory Support Advanced Angioplasty 2003 Andreas Baumbach Bristol Royal Infirmary.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Erle H. Austin, MD Kosair Children’s Hospital Louisville, Kentucky
Balloon-pump assisted Coronary Intervention Study BCIS-1 Simon Redwood Divaka Perera, Rod Stables, Martyn Thomas.
H. Amoozgar, MD Professor of pediatric cardiology Shiraz University of Medical Sciences, Shiraz, Iran TRANSCATHETER CLOSURE OF LARGE CORONARY-CAMERAL FISTULAE.
Lund – Malmö, SWEDEN. Is the Era of Off-pump Surgery over? ARASH MOKHTARI, MD, PHD.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Clinical Trial Results. org Impact of Epicardial Anterior Fat Pad Retention on Postcardiothoracic Surgery Atrial Fibrillation Incidence: The AFIST-III.
ATRIAL ESOPHAGEAL FISTULA SECONDARY TO ABLATION FOR ATRIAL FIBRILLATION: A CASE SERIES AND REVIEW OF THE LITERATURE 1 Lily K. Fatula, BS; 1,2 William D.
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
VSD post TAVR: Mechanisms, Presentation and Management
Ventricular Septal Defect Double Chamber RV (DCRV)
ISCHEMIC HEART DISEASE
Mitral Regurgitation: Epidemiology, Pathophysiology and When to Repair
Trans-Catheter Aortic Pseudo-Aneurysm Repair
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Acute Myocardial Infarction and Cardiac Arrest Due to Coronary Artery Perforation After Mitral Valve Surgery : Successful Treatment with a Covered Stent.
Improving Outcomes in Cardiogenic Shock
University of Cincinnati Medical Center
Clinical Presentation
Percutaneous Closure of a Coronary Fistula
Fig. 1 Clinical model of coronary collateral flow
Edward Howard MBChB(Hons) PhD Robert Lager MD Augusto Pichard MD
Dr M B Connellan Stellenbosch University
Intra-Aortic Balloon Pump For Complex Calcified Left-Main Bifurcation Lesion Supawat Ratanapo, MD Medical College of Georgia, Augusta University.
Mechanical circulatory support
One-stop Hybrid Cardiac Surgery
Table 1 Hospital mortality
S.G. Worthley, MB, BS, PhD., S. Redwood, MD, PhD.,
Balloon-pump assisted Coronary Intervention Study (BCIS-1):
Fig. 3 Summary estimates of the relative risks for the different surgical techniques for late mortality. Comparing the two main techniques, EVR showed.
Acute Myocardial Infarction and Cardiac Arrest Due to Coronary Artery Perforation After Mitral Valve Surgery : Successful Treatment with a Covered Stent.
Open Repair of Ruptured Descending Thoracic and Thoracoabdominal Aortic Aneurysms in 100 Consecutive Cases Mario F. Gaudino, Christopher Lau, Monica Munjal,
Ventricular Septal Defect Pre-PICU Clinical Pathway
Cardiovacular Research Technologies
Jeff Macemon Waikato Cardiothoracic Unit
Mechanical Complications of Acute Myocardial Infarction
Sitaram M. Emani, MD, Pedro J. del Nido, MD 
Alternative method of patch implantation and creation for postinfarction ventricular septal defect repair by the infarct exclusion technique  Masashi.
Outcomes of surgical repair of pediatric coronary artery fistulas
Isolated fracture of the ventricular septum after blunt chest trauma
A novel surgical approach to close an acute ventricular septal defect using an occluder device  Chanaka Rajakaruna, MRCS, Jonathan Hill, MA, MRCP, Eleanor.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Unifocalization of major aortopulmonary collateral arteries in pulmonary atresia with ventricular septal defect is essential to achieve excellent outcomes.
T Salah, MD., M Saber, MBBCh., T ElTaweil, MD. and N Rasmy,MD.
Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation: a propensity score matched analysis Maurizio Taramasso MD, PhD from.
Presentation transcript:

Surgically-BasedDevice VSD Closure Olaf Wendler Department of Cardiothoracic Surgery King‘s College Hospital

NO CONFLICT OF INTEREST TO DECLARE

Conventional Surgical Treatment Background Early clinical outcome after surgical repair of acute ischemic VSD is poor (mortality 30-50%) - Cardiogenic shock - Recurrent VSD - Complications from prolonged ITU 1. Jeppsson A et al. Eur J Cardio-thorac Surg Jeppsson A et al. Eur J Cardio-thorac Surg David TE et al. J Thorac Cardiovasc Surg David TE et al. J Thorac Cardiovasc Surg 1995

Interventional VSD-Closure Device closure is established as an option Device closure is established as an option for VSD closure in paediatric patients for VSD closure in paediatric patients Case series of ischaemic VSD’s reported Case series of ischaemic VSD’s reported Interventional VSD-Closure N=18, 5 pts with acute iVSD, early survival 40%

Hypothesis Hypothesis for Pilot Trial Direct surgical closure of an acute iVSD using an VSD device toDirect surgical closure of an acute iVSD using an Amplatzer ® muscular VSD device to Reduce cardiac traumaReduce cardiac trauma –Avoid left ventriculotomy –Reduce CPB time –Avoid cardiac arrest Achieve full revascularisationAchieve full revascularisation Reduce incidence of recurrent VSDReduce incidence of recurrent VSD Simplify device deploymentSimplify device deployment (Ethically approved by the King’s Novel Procedures Committee) (Ethically approved by the King’s Novel Procedures Committee)

Case Report A novel surgical approach to close an acute ventricular septal defect using an occluder device Chanaka Rajakaruna (MRCS), Jonathan Hill (MA, MRCP), Eleanor Jane Holland Turner (BSc, PhD, MRCS), Alex Sirker (MRCP), Bushra S Rana (MRCP), Olaf Wendler (MD, PhD, FRCS) Departments of Cardiothoracic Surgery and Cardiology, Kings College Hospital, London. UK.

Case Report 75 y, male no past medical History Presentation – –Anterior MI – –iVSD 4 d pMI – –Pulmonary oedema – –Cardiogenic shock Patient Data

Case Report ECHO Anterior VSD (7-9 mm)Anterior VSD (7-9 mm) L to R shunt (Qp:Qs = 4:1)L to R shunt (Qp:Qs = 4:1) LVEF 45%LVEF 45% RV preservedRV preserved PAP 50 mmHgPAP 50 mmHg

Case Report Preoperative Treatment Insertion of IABPInsertion of IABP Coronary angiographyCoronary angiography –LAD 95%, D1 75% –Cx normal –RCA occluded, Crux 70% Scheduled for surgery when he deterioratedScheduled for surgery when he deteriorated 10 pMI ( ).

Case Report Operation (I) Midline sternotomy & aorto-bicaval cannulationMidline sternotomy & aorto-bicaval cannulation On-pump beating heartOn-pump beating heart –Sequential LIMA to LAD & D1 –Sequential SVG to LV branch & PDA Epicardial 3-D-ECHOEpicardial 3-D-ECHO –VSD of mm in the mid septum

Case Report Operation (II) VF induced Incision (1.5cm) in the anterior wall of the RV VSD size 20mm, Device 24mm Device deployed, direct vision RV closed after de-airing The patient weaned off CPB with IABP and Noradrenaline (0.09mcg/kg/hr)

Case Report Postoperative Course Early extubation (6 hours pOP)Early extubation (6 hours pOP) IABP for 48 hoursIABP for 48 hours Furosemide infusion (5-10mg/hr)Furosemide infusion (5-10mg/hr) Adrenaline and Noradrenaline ( mcg/kg/hr)Adrenaline and Noradrenaline ( mcg/kg/hr) ComplicationsComplications –Chest infection –Haemothorax secondary to chest drain (day 20) Discharged on day 32Discharged on day 32

Case Report 6 - Months Follow-Up AsymptomaticAsymptomatic NYHA INYHA I ECHOECHO - Device well seated - Residual shunt through device through device (Qp:Qs=2:1) (Qp:Qs=2:1) PAP 20 mmHgPAP 20 mmHg

Summary Summary Potential advantages vs. Conventional surgery Conventional surgery - No incision in the LV - No incision in the LV - Reduced CPB time - Reduced CPB time - No cardiac arrest - No cardiac arrest Interventional treatment Interventional treatment - Device deployed under direct vision - Device deployed under direct vision - Complete revascularization - Complete revascularization

Conclusion Conclusion Limitation - Residual shunt through the device - Residual shunt through the deviceOutlook - Earlier intervention may improve outcome - Earlier intervention may improve outcome - Improve surgical technique - Improve surgical technique - Modification of the device - Modification of the device